Direxion Daily MSFT (MSFD) ニュース

Alzheimer's & Dementia would be a good journal to publish the study. They actually do recommend that the SAP be uploaded. However, the 2020 phase 2a paper did not include this in the supporting/supplementary data. The SAP / protocol for a phase 2 trial is less important as it is not a registrati

Thats great news, thanks for sharing. Can we get more information on there business friendship.

Company silence since the august post has been deafening..they must be too busy producing Xmax gifts for shareholders!

Full blown .0011's
Not the half baked .00105
Up 22%

Yeah Nick, let me in please. @LarryAWood1

Thanks.

I just read the last paragraphs from large pharma companies quarterly meeting transcripts and majority of them including McKesson are looking to acquire companies. The pharma acquisition and merger forecast is forecast to be huge in 2025.

It says it right in the financials Steal,

$GEVI These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.

And the countdown begins

$NNVC gains 2.81%, now $1.3776—progress fueling excitement!
https://iotracker96.com/Ry2vp

Another tweet: https://x.com/BlueBiofuels/status/1861064314641125480

I hates gaps here, will this be a runaway gap, will volume sustain it, if not, fill and then go back up.

VUZI..................MULN.......................https://stockcharts.com/h-sc/ui?s=MULN&p=W&b=5&g=0&id=p84354014936

GEVI has ONLY 4 customers and Q1 only did GROSS revs of $400k and last 2 Qs tad over $100k gross revenue per Q, Lost 5 million and NOW GEVI as per S1 statement and what was stated in the recent Q subsequent events we can do the math and that GEVI is planning to sell their Offering of 3,500,000 to ra

I don't believe they do . They need some cheese to go with their " wine" LOL

When shares trade on the offer they offer at a lower price, when shares trade on the bid, bid goes lower.

 

You want to reap a reward here?

You've been told how that can happen.
There is no Hans to file anything.

I believe the control person at MEDH is still listed as Jason Black.
I'd say the ball's in his court and he'd better play his hand with shareholders in

Benz selling? 

You still have 3 years per the requirements needed to uplist to NYSE. Below is some education material for you so that you can stop spreading misinformation.

• EARNINGS TEST: Adjusted pre -tax earnings from continuing operations must total (1) $10 million for the last three fiscal yea

Get burned that bad?

Wow!

From Stilton Jarlsberg:
https://blogger.googleusercontent.com/img/a/AVvXsEhYRzA5mGamEKIFwoNlJVqMhdpzLItTQ4F8YWJD5QDrtwpFkA8C9vDVBGu7_C-TVPYR1ktW0yOpMxqFMY8CUX90cYSDT2rpkC9WIxTE6ptGx_goTNUnqr7cy9nV_T5eAbwHTvXdyKoMVKIY-Vqywi3UYFqFTveMvIBIYsa2wdjVLDEyUx1_34GDmy2W07I=w640-h306

More

Gary Gensler is useless , apparently schmoozing with the likes of Sam Bankman-Fried! :p ~realistically how could we expect anything to change under his watch?

...you wanna head the SEC next year? ;) cheers!

Our MC is now roughly 4X more than SAVA's

800 mill
200 mill

Biotech is incredibly brutal, and no mercy will be shown if you fail.

Adnexus Biotechnologies Inc., a staking target of 1606 Corp. (OTC PINK: $CBDW), has announced a game-changing merger with Sanctum Therapeutics. https://allcapresearch.com/f/adnexus-biotech-and-sanctum-merge-for-breakthrough-hiv-treatment

Adnexus Biotechnologies Inc., a staking target of 1606 Corp. (OTC PINK: $CBDW), has announced a game-changing merger with Sanctum Therapeutics. https://allcapresearch.com/f/adnexus-biotech-and-sanctum-merge-for-breakthrough-hiv-treatment

$RDAR 11's printed